Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

66 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Eligibility Chronic Lymphocytic Leukemia NCT00558961

- 07/11/16 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00558961

Eligibility Leukemia, Lymphocytic, Chronic NCT00083473

- 07/10/16 - 1 modulo, 2 itemgroups, 17 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00083473

Eligibility Leukemia NCT00452374

- 07/10/16 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL; ODM derived from: https://clinicaltrials.gov/show/NCT00452374

Eligibility Leukemia NCT00262795

- 05/10/16 - 1 modulo, 1 ItemGroup, 26 elementi, 1 linguaggio
ItemGroup: Criteria
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00262795

Eligibility Leukemia NCT00525603

- 08/08/16 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
CFAR Study in Patients With Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00525603

Eligibility Chronic Lymphocytic Leukemia NCT00193518

- 07/08/16 - 1 modulo, 2 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00193518

Eligibility Chronic Lymphocytic Leukemia NCT00337519

- 01/08/16 - 1 modulo, 2 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00337519

Eligibility Chronic Lymphocytic Leukemia NCT00233506

- 01/08/16 - 1 modulo, 2 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Dose Finding Study of CpG in Patients With Chronic Lymphocytic Leukemia Who Have Been Previously Treated; ODM derived from: https://clinicaltrials.gov/show/NCT00233506

Eligibility Chronic Lymphocytic Leukemia NCT00131313

- 01/08/16 - 1 modulo, 2 itemgroups, 21 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.; ODM derived from: https://clinicaltrials.gov/show/NCT00131313

Eligibility Chronic Lymphocytic Leukemia NCT00100711

- 01/08/16 - 1 modulo, 2 itemgroups, 18 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00100711

Eligibility Chronic Lymphocytic Leukemia NCT00093314

- 01/08/16 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
HuMax-CD20 in Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00093314

Eligibility B-cell Chronic Lymphocytic Leukemia NCT00098670

- 04/07/16 - 1 modulo, 1 ItemGroup, 19 elementi, 1 linguaggio
ItemGroup: Inclusion Criteria
Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00098670

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial